Patents Prosecuted
Application number | Title of the patent | IPC | Filing Date | Decision Date |
---|---|---|---|---|
16992196 | THERAPEUTIC IMMUNE CELLS WITH IMPROVED FUNCTION AND METHODS FOR MAKING THE SAME | C07K, A61K, C12N | Aug 12, 2020 | Oct 5, 2023 |
16986615 | Anti-PHF-tau antibodies and uses thereof | G01N, A61K, A61P, C07K | Aug 5, 2020 | Jun 20, 2022 |
16936719 | ANTI-HK2 CHIMERIC ANTIGEN RECEPTOR (CAR) | C07K, A61K | Jul 22, 2020 | |
16935121 | NOVEL AAV MEDIATED INFLUENZA VACCINES | A61K, C07K, A61P, C12N | Jul 20, 2020 | Jan 11, 2023 |
17633996 | OPTIMIZED CULTURE MEDIA FOR CLOSTRIDIA BACTERIA | C12N | Jul 20, 2020 | |
17633991 | OPTIMIZED CULTURE MEDIA FOR CLOSTRIDIA BACTERIA | C12N | Jul 20, 2020 | |
16934970 | SYNTHETIC GENETIC ELEMENTS FOR BIOMANUFACTURE | C12N | Jul 20, 2020 | |
16892106 | USE OF NOGGIN, AN ALK5 INHIBITOR AND A PROTEIN KINASE C ACTIVATOR, TO PRODUCE ENDOCRINE CELLS | C12N | Jun 2, 2020 | Jan 27, 2023 |
16880118 | Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha | A61P, A61K, C07K | May 20, 2020 | Oct 9, 2023 |
15931726 | Combination therapies with bispecific anti-EGFR/c-Met antibodies and third generation EGFR tyrosine kinase inhibitors | A61P, C07K, A61K | May 13, 2020 | Jan 22, 2024 |
16869771 | Macrocyclic chelators and methods of use thereof | A61K | May 7, 2020 | Feb 13, 2023 |
16869401 | Materials and methods for modulating t cell mediated immunity | A61K, C07K | May 6, 2020 | Jun 5, 2023 |
17607235 | PAR2 MODULATION AND METHODS THEREOF | A61K, G01N, C07K | Apr 29, 2020 | Nov 18, 2023 |
16860613 | Fibronectin type III domain based scaffold compositions, methods and uses | C07K, C40B | Apr 27, 2020 | Oct 24, 2022 |
17594532 | ANTIBODY FORMULATION | A61P, C07K | Apr 21, 2020 | |
16853786 | Nucleic acids encoding anti-CD154 antibodies | A61K, C07K | Apr 20, 2020 | Aug 22, 2022 |
17595160 | Efficient Impurity Removal Using A Diafiltration Process | C12N | Apr 20, 2020 | |
17602156 | SIALYLATED GLYCOPROTEINS | C07K, A61K | Apr 16, 2020 | |
16850171 | Dihydroorotate dehydrogenase inhibitors | C07D | Apr 15, 2020 | Nov 21, 2022 |
16840479 | CYSTEINE ENGINEERED FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES | C07K, C12N | Apr 5, 2020 | Feb 9, 2023 |